Zhan Wang

发表

Analysis of renal lesions in Chinese tuberous sclerosis complex patients with different types of TSC gene mutations

Xu Wang, Han-Zhong Li, Wenda Wang, 2022, Genetics and molecular biology.

Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China

Xu Wang, Wenda Wang, Yushi Zhang, 2022, Frontiers in Medicine.

Analysis of serum lipid parameters predicting lipid metabolic disorders in TSC‐AML patients with treatment of mTOR inhibitors

Xu Wang, Han-Zhong Li, Wenda Wang, 2022, Journal of clinical pharmacy and therapeutics.

A multi-omics study of diagnostic markers and the unique inflammatory tumor micro-environment involved in tuberous sclerosis complex-related renal angiomyolipoma

X. Liu, Wei Sun, Haidan Sun, 2022, International journal of oncology.

UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma

X. Liu, Wei Sun, Zhengguang Guo, 2019, BMC Cancer.

Construction of TSC2 knockout cell line using CRISPR/Cas9 system and demonstration of its effects on NIH-3T3 cells

Xu Wang, Yushi Zhang, Yang Zhao, 2022, Cell Biochemistry and Biophysics.

Solitary vaginal paraganglioma with mature sacrococcygeal teratoma: a rare case report

S. Seery, Wenda Wang, Yushi Zhang, 2021, BMC Endocrine Disorders.

UPLC-MS based integrated plasma proteomic and metabolomic profiling of TSC-RAML and its relationship with everolimus treatment

X. Liu, Xu Wang, Wei Sun, 2023, Frontiers in Molecular Biosciences.

Investigation of Plasma Metabolic and Lipidomic Characteristics of a Chinese Cohort and a Pilot Study of Renal Cell Carcinoma Biomarker

X. Liu, Yajie Wang, S. Tsang, 2020, Frontiers in Oncology.

LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma

X. Liu, Wei Sun, Zhengguang Guo, 2020, Frontiers in Oncology.

Re: Masayuki Hagiwara, Atsushi Fushimi, Kazuhiro Matsumoto, Mototsugu Oya. The Significance of PARP1 as a Biomarker for Predicting the Response to PD-L1 Blockade in Patients with PBRM1-mutated Clear Cell Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.09.024

Yushi Zhang, Yang Zhao, Zhan Wang, 2021, European Urology.

Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC

X. Liu, Wei Sun, Zhengguang Guo, 2019, Front. Oncol..

Pure androgen-secreting adrenal tumor (PASAT): A rare case report of bilateral PASATs and a systematic review

Xu Wang, Yang Zhao, Jia-quan Zhou, 2023, Frontiers in Endocrinology.

Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Predicting Prognosis of Surgically Resectable Urinary Cancers: Systematic Review and Meta-Analysis.

Xu Wang, Hao Guo, Zhan Wang, 2020, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

LncCCLM inhibits lymphatic metastasis of cervical cancer by promoting STAU1-mediated IGF-1 mRNA degradation.

Yali Chen, Wei Sun, Shouyu Wang, 2021, Cancer letters.

High Preoperative Plasma Fibrinogen Independently Predicts a Poor Prognosis in Patients with Nonmetastatic RCC

Wenda Wang, Hao Guo, Yushi Zhang, 2020, Journal of Cancer.

Re: Oscar Reig Torras, Akhilesh Mishra, Alana Christie, et al. Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.003.

Yushi Zhang, Yang Zhao, Zhan Wang, 2022, European urology.

High-throughput screening of circRNAs reveals novel mechanisms of tuberous sclerosis complex-related renal angiomyolipoma

Xu Wang, Wenda Wang, Hao Guo, 2021, Human genomics.

PMEL is a predictive biomarker for mTORC1 inhibitor treatment of renal angiomyolipoma in tuberous sclerosis complex patients

Xu Wang, Wenda Wang, Zhan Wang, 2024, Heliyon.